Free Trial

Arbutus Biopharma (ABUS) Institutional Ownership

Arbutus Biopharma logo
$4.04 +0.33 (+8.76%)
As of 10:54 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Arbutus Biopharma (NASDAQ:ABUS)

Current
Institutional Ownership
Percentage
43.79%
Number of
Institutional Buyers
(last 12 months)
80
Total
Institutional Inflows
(last 12 months)
$69.21M
Number of
Institutional Sellers
(last 12 months)
36
Total
Institutional Outflows
(last 12 months)
$16.50M
Get ABUS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Arbutus Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ABUS Institutional Buying and Selling by Quarter

Arbutus Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/18/2025 Hudson Bay Capital Management LP965,000$2.98M0.0%-22.5%0.503%
8/15/2025 Tower Research Capital LLC TRC 20,760$64K0.0%+220.1%0.011%
8/15/2025 Exome Asset Management LLC75,484$233K0.1%N/A0.039%
8/15/2025 Rafferty Asset Management LLC88,454$273K0.0%+6.7%0.046%
8/15/2025 Rangeley Capital LLC865,000$2.67M3.3%-35.9%0.451%
8/15/2025 Rubric Capital Management LP1,575,376$4.87M0.1%-6.3%0.822%
8/15/2025 Oxford Asset Management LLP12,143$38K0.0%N/A0.006%
8/15/2025 Man Group plc38,997$121K0.0%N/A0.020%
8/15/2025 Hudson Bay Capital Management LP965,000$2.98M0.0%-22.5%0.503%
8/15/2025 BNP Paribas Financial Markets55,951$173K0.0%-69.5%0.029%
8/15/2025 Boothbay Fund Management LLC262,277$810K0.0%+61.6%0.137%
8/15/2025 BlackBarn Capital Partners LP2,603,521$8.05M0.5%+11.2%1.358%
8/15/2025 Bank of America Corp DE1,197,655$3.70M0.0%+161.4%0.625%
8/15/2025 Adage Capital Partners GP L.L.C.2,575,941$7.96M0.0%+63.5%1.344%
8/15/2025 Ameriprise Financial Inc.11,440$35K0.0%-39.2%0.006%
8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.87,349$270K0.0%-4.2%0.046%
8/14/2025 Caption Management LLC41,866$129K0.0%+73.0%0.022%
8/14/2025 The Manufacturers Life Insurance Company 59,350$183K0.0%+6.3%0.031%
8/14/2025 Qube Research & Technologies Ltd368,030$1.14M0.0%+24.6%0.192%
8/14/2025 Daiwa Securities Group Inc.15,844$49K0.0%+3,911.1%0.008%
8/13/2025 Two Seas Capital LP10,443,317$32.27M0.5%+10.3%5.448%
8/13/2025 Kennedy Capital Management LLC449,179$1.39M0.0%+7.1%0.234%
8/13/2025 Invesco Ltd.181,084$560K0.0%+29.8%0.094%
8/13/2025 Schroder Investment Management Group121,313$375K0.0%N/A0.063%
8/13/2025 Virtus Investment Advisers LLC26,266$81K0.0%-43.0%0.014%
8/12/2025 XTX Topco Ltd23,914$74K0.0%-67.0%0.012%
8/12/2025 Prudential Financial Inc.18,255$56K0.0%+71.5%0.010%
8/12/2025 Rhumbline Advisers207,805$642K0.0%+3.5%0.108%
8/12/2025 Franklin Resources Inc.104,423$323K0.0%+13.0%0.054%
8/12/2025 Legal & General Group Plc124,486$385K0.0%+5.1%0.065%
8/12/2025 JPMorgan Chase & Co.86,077$266K0.0%-84.0%0.045%
8/12/2025 Ensign Peak Advisors Inc45,000$139K0.0%+105.9%0.023%
8/8/2025 Creative Planning52,938$164K0.0%-14.7%0.028%
8/8/2025 Geode Capital Management LLC3,637,021$11.24M0.0%+2.7%1.899%
8/8/2025 SBI Securities Co. Ltd.43,294$134K0.0%-45.1%0.023%
8/7/2025 Los Angeles Capital Management LLC19,655$61K0.0%N/A0.010%
8/5/2025 Bank of Montreal Can600,430$1.86M0.0%+3.3%0.313%
8/4/2025 Wealth Management Associates Inc.104,920$324K0.1%+8.8%0.055%
7/29/2025 VIRGINIA RETIREMENT SYSTEMS ET Al36,300$112K0.0%N/A0.019%
7/24/2025 Aberdeen Group plc982,527$3.04M0.0%+110.2%0.513%
GENIUS Act: Cancel Your Money? (Ad)

They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—not the government—have been handed control of a new class of programmable money. It’s not called a CBDC, but it acts just like one. Your spending could be tracked, limited, or even frozen—whether you opt in or not. Once this system becomes the default, escape won’t be easy.tc pixel

Get the free info kit with 3 ways to protect your money before control kicks in.
7/11/2025 Assenagon Asset Management S.A.39,610$122K0.0%N/A0.021%
6/27/2025 Goldman Sachs Group Inc.2,075,948$7.25M0.0%+290.3%1.084%
6/18/2025 Voya Investment Management LLC41,523$145K0.0%-9.8%0.022%
5/29/2025 Rhumbline Advisers200,757$701K0.0%+6.4%0.105%
5/28/2025 Wealth Management Associates Inc.96,420$337K0.1%+58.0%0.050%
5/16/2025 Woodline Partners LP2,655,738$9.27M0.1%+173.3%1.387%
5/16/2025 Goldman Sachs Group Inc.2,075,948$7.25M0.0%+290.3%1.084%
5/16/2025 Two Seas Capital LP9,465,956$33.04M1.0%+8.3%4.944%
5/16/2025 Adage Capital Partners GP L.L.C.1,575,941$5.50M0.0%-4.5%0.823%
5/16/2025 ADAR1 Capital Management LLC1,879,114$6.56M1.2%+20.9%0.981%
5/14/2025 Rafferty Asset Management LLC82,864$289K0.0%-43.6%0.043%
5/14/2025 MetLife Investment Management LLC88,887$310K0.0%+8.9%0.046%
5/14/2025 EntryPoint Capital LLC18,730$65K0.0%N/A0.010%
5/13/2025 Aberdeen Group plc467,383$1.63M0.0%N/A0.244%
5/12/2025 Nuveen LLC313,307$1.09M0.0%N/A0.164%
5/12/2025 Invesco Ltd.139,462$487K0.0%+99.7%0.073%
5/12/2025 Mitsubishi UFJ Asset Management Co. Ltd.76,031$265K0.0%+9.1%0.040%
5/9/2025 Deutsche Bank AG146,863$513K0.0%-14.5%0.077%
5/9/2025 Vanguard Group Inc.8,953,823$31.25M0.0%-0.3%4.676%
5/8/2025 XTX Topco Ltd72,412$253K0.0%+37.7%0.038%
5/7/2025 Zurcher Kantonalbank Zurich Cantonalbank84,163$294K0.0%-6.1%0.044%
5/2/2025 SBI Securities Co. Ltd.78,894$275K0.0%+9.2%0.041%
4/29/2025 Bank of New York Mellon Corp348,797$1.22M0.0%-1.3%0.182%
4/28/2025 Teacher Retirement System of Texas38,248$133K0.0%-9.2%0.020%
4/17/2025 Cyndeo Wealth Partners LLC10,000$35K0.0%N/A0.005%
4/8/2025 Rhumbline Advisers200,757$701K0.0%+6.4%0.105%
3/24/2025 Wellington Management Group LLP513,302$1.68M0.0%+3.3%0.271%
2/18/2025 Two Seas Capital LP8,740,956$28.58M2.2%+4.2%4.613%
2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC103,943$340K0.0%-46.9%0.055%
2/17/2025 Whitefort Capital Management LP13,241,916$43.30M20.8%+2.9%6.988%
2/17/2025 Woodline Partners LP971,628$3.18M0.0%+45.4%0.513%
2/17/2025 Saba Capital Management L.P.887,993$2.90M0.1%+31.3%0.469%
2/17/2025 Rafferty Asset Management LLC146,803$480K0.0%+27.6%0.077%
2/17/2025 ProShare Advisors LLC50,121$164K0.0%+29.3%0.026%
2/17/2025 Millennium Management LLC343,028$1.12M0.0%+36.7%0.181%
2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.89,397$292K0.0%+10.2%0.047%
2/17/2025 LMR Partners LLP158,249$517K0.0%-19.7%0.084%
2/17/2025 Hudson Bay Capital Management LP1,112,500$3.64M0.0%+8.0%0.587%
2/17/2025 Deutsche Bank AG171,766$562K0.0%+77.9%0.091%
2/17/2025 Balyasny Asset Management L.P.41,690$136K0.0%N/A0.022%
2/17/2025 Bank of America Corp DE361,304$1.18M0.0%+90.8%0.191%
2/17/2025 BNP Paribas Financial Markets247,996$811K0.0%-19.1%0.131%
2/17/2025 Ameriprise Financial Inc.18,917$62K0.0%N/A0.010%
2/14/2025 Mercer Global Advisors Inc. ADV20,500$67K0.0%N/A0.011%
2/14/2025 Northern Trust Corp1,330,683$4.35M0.0%+8.3%0.702%
2/14/2025 Boothbay Fund Management LLC162,277$531K0.0%-73.5%0.086%
2/14/2025 Susquehanna Fundamental Investments LLC202,541$662K0.0%N/A0.107%
2/14/2025 Virtus ETF Advisers LLC19,970$65K0.0%-31.5%0.011%
2/14/2025 Two Sigma Securities LLC19,475$64K0.0%N/A0.010%
2/14/2025 Two Seas Capital LP8,740,956$28.58M2.5%+4.2%4.613%
IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead? (Ad)

On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel

Click here to download the guide and protect your assets before Sept 15th.
2/14/2025 Adage Capital Partners GP L.L.C.1,650,941$5.40M0.0%-43.1%0.871%
2/14/2025 Price T Rowe Associates Inc. MD56,452$185K0.0%+18.1%0.030%
2/14/2025 BlackBarn Capital Partners LP2,341,871$7.66M0.4%+13.1%1.236%
2/14/2025 Hsbc Holdings PLC16,994$55K0.0%N/A0.009%
2/13/2025 XTX Topco Ltd52,581$172K0.0%+75.2%0.028%
2/13/2025 Barclays PLC298,253$975K0.0%+9.6%0.157%
2/13/2025 Rockefeller Capital Management L.P.106,615$349K0.0%+69.2%0.056%
2/13/2025 Quinn Opportunity Partners LLC404,879$1.32M0.1%+72.2%0.214%
2/13/2025 Raymond James Financial Inc.10,504$34K0.0%N/A0.006%
2/13/2025 Legal & General Group Plc118,693$388K0.0%-18.6%0.063%
(Data available from 1/1/2016 forward)

ABUS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ABUS shares?

During the previous two years, 106 institutional investors and hedge funds held shares of Arbutus Biopharma. The most heavily invested institutionals were Whitefort Capital Management LP ($43.30M), Two Seas Capital LP ($32.27M), Vanguard Group Inc. ($31.25M), State Street Corp ($16.97M), Geode Capital Management LLC ($11.24M), Woodline Partners LP ($9.27M), and BlackBarn Capital Partners LP ($8.05M).Learn more on Arbutus Biopharma's institutional investors.

What percentage of Arbutus Biopharma's stock is owned by institutional investors?

43.79% of Arbutus Biopharma's stock is owned by institutional investors. Learn more on ABUS's institutional investor holdings.

Which institutional investors have been buying Arbutus Biopharma's stock?

Of the 91 institutional investors that purchased Arbutus Biopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Goldman Sachs Group Inc. ($3.09M), Two Seas Capital LP ($2.41M), Woodline Partners LP ($1.99M), Rubric Capital Management LP ($1.68M), State Street Corp ($1.47M), Rangeley Capital LLC ($1.46M), and Hudson Bay Capital Management LP ($1.39M).

How much institutional buying is happening at Arbutus Biopharma?

Institutional investors have bought a total of 20,340,804 shares in the last 24 months. This purchase volume represents approximately $69.21M in transactions.

Which of Arbutus Biopharma's major shareholders have been selling company stock?

Of the 36 institutional investors that sold Arbutus Biopharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($1.33M), Hudson Bay Capital Management LP ($561.80K), ADAR1 Capital Management LLC ($534.52K), Rangeley Capital LLC ($484K), JPMorgan Chase & Co. ($452.55K), Boothbay Fund Management LLC ($450K), and BNP Paribas Financial Markets ($227.54K).

How much institutional selling is happening at Arbutus Biopharma?

Institutional investors have sold a total of 5,075,821 shares in the last 24 months. This volume of shares sold represents approximately $16.50M in transactions.



This page (NASDAQ:ABUS) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners